Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53’s tumor suppression

Józefa Węsierska-Gądek
  • Future Medicinal Chemistry, April 2018, Future Science
  • DOI: 10.4155/fmc-2017-0175
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: